VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 12, 2007) - Med BioGene Inc. (TSX VENTURE:MBI), a life science company focused on the development and commercialization of genomic-based diagnostic and screening tests for cancer and cardiovascular disease, is pleased to welcome Sandeep S. Dave, M.D. of Duke University to its lymphoma collaboration. MBI and Duke entered into a research collaboration and option agreement in March 2007.
